Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 5/20 | 0.54 |
| ▸ | FEN1 | P39748 | 5/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.50 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.50 |
| ▸ | F10 | P00742 | 3/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | FES | P07332 | 1/20 | 0.47 |
| ▸ | FER | P16591 | 1/20 | 0.47 |
| ▸ | MARK3 | P27448 | 1/20 | 0.47 |
| ▸ | FLT3 | P36888 | 1/20 | 0.47 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.47 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.47 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.47 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.47 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.47 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6303170 | 0.83 | MKNK1 (0.54) | MKNK1MKNK2F10F2PRSS1 | |
| SCHEMBL7112360 | 0.81 | CA2 (0.56) | MKNK1MKNK2F10F2PRSS1 | |
| SCHEMBL6698432 | 0.80 | ALOX5AP (0.58) | ALOX5APFEN1PDPK1ROCK2FES | |
| SCHEMBL9306541 | 0.80 | ALOX5AP (0.57) | ALOX5APFEN1PDPK1ROCK2FES | |
| SCHEMBL28264223 | 0.76 | MKNK1 (0.61) | MKNK1MKNK2ALDH1A1CA12CA1 | |
| SCHEMBL2997436 | 0.74 | ALDH1A1 (0.47) | F2PRSS1IRAK4ALDH1A1SMN1; SMN2 | |
| SCHEMBL4639473 | 0.73 | CA2 (0.59) | ALDH1A1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL9451155 | 0.72 | POLB (0.61) | MKNK1MKNK2ALDH1A1CA12CA1 | |
| SCHEMBL2950525 | 0.72 | MKNK1 (0.60) | MKNK1MKNK2CA12CA1CA2 | |
| SCHEMBL10957993 | 0.71 | SMN1; SMN2 (0.46) | ALOX5APFEN1PDPK1ROCK2FES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12269814-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2025-04-08 | — | — | US | claimed |
| US-20230295133-A1 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | PULMOCIDE LIMITED (GB) | 2023-09-21 | — | — | US | claimed |
| US-11661415-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2023-05-30 | — | — | US | claimed |
| US-12269814-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2025-04-08 | — | — | US | disclosed |
| US-20230295133-A1 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | PULMOCIDE LIMITED (GB) | 2023-09-21 | — | — | US | disclosed |
| US-11661415-B2 | Process for preparing a compound useful to treat mycoses | PULMOCIDE LIMITED (GB) | 2023-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661415-B2 | Process for preparing a compound useful to treat mycoses | DPM1, CYP51A1, ERG28 | ALOX5AP 2196/4885FEN1 2446/4885MKNK1 1902/4885 |
| US-20230295133-A1 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | DPM1, CYP51A1, ERG28 | ALOX5AP 2196/4885FEN1 2446/4885MKNK1 1902/4885 |
| US-12269814-B2 | Process for preparing a compound useful to treat mycoses | C1R, CBR1, CBR3 | ALOX5AP 2846/4885FEN1 3708/4885MKNK1 4079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.